Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS
Provided By GlobeNewswire
Last update: May 15, 2025
LOUISVILLE, Colo., May 15, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced that new data will be presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2025 Annual Meeting in Montreal, Quebec and at the American Thoracic Society (ATS) 2025 International Conference in San Francisco, California.
Read more at globenewswire.com
